Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tavan Janvilisri

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Microbiology Spectrum|February 5, 2024
Identification of a microbial sub-community from the feral chicken gut that reduces <i>Salmonella</i> colonization and improves gut health in a gnotobiotic chicken modelSupapit Wongkuna, Achuthan Ambat, Sudeep Ghimire, et al.
Scientific Reports|September 17, 2024
Author Correction: Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial-to-mesenchymal transition of cholangiocarcinoma cellsKittiya Islam, Brinda Balasubramanian, Simran Venkatraman, et al.
Scientific Reports|December 19, 2023
Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cellsKittiya Islam, Brinda Balasubramanian, Simran Venkatraman, et al.
Cancers|May 13, 2023
Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in CholangiocarcinomaBrinda Balasubramanian, Kiren Yacqub-Usman, Simran Venkatraman, et al.
Cancers|January 8, 2025
Identification of Transcriptional Regulators of Immune Evasion Across Cancers: An Alternative Immunotherapeutic Strategy for CholangiocarcinomaSimran Venkatraman, Brinda Balasubramanian, Pornparn Kongpracha, et al.
Pharmaceuticals (Basel, Switzerland)|January 26, 2024
CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in <i>Opisthorchis viverrini</i>-Associated Cholangiocarcinoma via Nrf2 Suppression and Enhanced ROSJinchutha Duangdara, Boonyakorn Boonsri, Apinya Sayinta, et al.
Frontiers in Oncology|December 25, 2023
Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinomaKyaw Zwar Myint, Mireia Sueca-Comes, Pamela Collier, et al.
Cancer Research and Treatment|October 19, 2020
Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma CellsBoonyakorn Boonsri, Kiren Yacqub-Usman, Pakpoom Thintharua, et al.
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and MutationKyaw Zwar Myint, Brinda Balasubramanian, Simran Venkatraman, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Microbiology Spectrum|February 5, 2024
Identification of a microbial sub-community from the feral chicken gut that reduces <i>Salmonella</i> colonization and improves gut health in a gnotobiotic chicken modelSupapit Wongkuna, Achuthan Ambat, Sudeep Ghimire, et al.
Scientific Reports|September 17, 2024
Author Correction: Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial-to-mesenchymal transition of cholangiocarcinoma cellsKittiya Islam, Brinda Balasubramanian, Simran Venkatraman, et al.
Scientific Reports|December 19, 2023
Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cellsKittiya Islam, Brinda Balasubramanian, Simran Venkatraman, et al.
Cancers|May 13, 2023
Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in CholangiocarcinomaBrinda Balasubramanian, Kiren Yacqub-Usman, Simran Venkatraman, et al.
Cancers|January 8, 2025
Identification of Transcriptional Regulators of Immune Evasion Across Cancers: An Alternative Immunotherapeutic Strategy for CholangiocarcinomaSimran Venkatraman, Brinda Balasubramanian, Pornparn Kongpracha, et al.
Pharmaceuticals (Basel, Switzerland)|January 26, 2024
CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in <i>Opisthorchis viverrini</i>-Associated Cholangiocarcinoma via Nrf2 Suppression and Enhanced ROSJinchutha Duangdara, Boonyakorn Boonsri, Apinya Sayinta, et al.
Frontiers in Oncology|December 25, 2023
Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinomaKyaw Zwar Myint, Mireia Sueca-Comes, Pamela Collier, et al.
Cancer Research and Treatment|October 19, 2020
Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma CellsBoonyakorn Boonsri, Kiren Yacqub-Usman, Pakpoom Thintharua, et al.
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and MutationKyaw Zwar Myint, Brinda Balasubramanian, Simran Venkatraman, et al.
Pageof 9